Mehlika Toy
Biographic Data
| ID | 5536141 |
|---|---|
| NAME | Mehlika Toy |
| GIVEN NAMES | Mehlika |
| FAMILY NAME | Toy |
| SIGNATURE | TOY M |
| AFFILIATIONS | Palo Alto University |
| ORCID | 0000-0001-7848-4816 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Gaps and Disparities in Chronic Hepatitis B Monitoring and Treatment in the United States, 2016-2019
BACKGROUND: Chronic hepatitis B (CHB) carries an increased risk of death from cirrhosis and hepatocellular carcinoma (HCC). The American Association for the Study of Liver Diseases recommends patients with CHB receive monitoring of disease activity, including ALT, hepatitis B virus (HBV) DNA, hepatitis B e-antigen (HBeAg), and liver imaging for patients who experience an increased risk for HCC. HBV antiviral therapy is recommended for patients wi…
Costs and health impact of delayed implementation of a national hepatitis B treatment program in China
Background: Hepatitis B virus (HBV) infection is a leading public health problem in China. COVID-19 pandemic has interrupted the delivery of health care interventions worldwide, including HBV infection control. Methods: In this study, we used a Markov model to quantify the costs and population health impact of HBV treatment in China for the following scenarios: 1) current practice with only 17% of treatment eligible HBV infected adults receiving …
Knowledge and Attitude Related to Hepatitis C among Medical Students in the Oral Direct Acting Antiviral Agents Era in Vietnam
This study points out the need to update the medical training curriculum to improve the knowledge and attitude of students about hepatitis C infection
No prominent works on this page.
Costs and health impact of delayed implementation of a national hepatitis B treatment program in China
Background: Hepatitis B virus (HBV) infection is a leading public health problem in China. COVID-19 pandemic has interrupted the delivery of health care interventions worldwide, including HBV infection control. Methods: In this study, we used a Markov model to quantify the costs and population health impact of HBV treatment in China for the following scenarios: 1) current practice with only 17% of treatment eligible HBV infected adults receiving …
Knowledge and Attitude Related to Hepatitis C among Medical Students in the Oral Direct Acting Antiviral Agents Era in Vietnam
This study points out the need to update the medical training curriculum to improve the knowledge and attitude of students about hepatitis C infection
Gaps and Disparities in Chronic Hepatitis B Monitoring and Treatment in the United States, 2016-2019
BACKGROUND: Chronic hepatitis B (CHB) carries an increased risk of death from cirrhosis and hepatocellular carcinoma (HCC). The American Association for the Study of Liver Diseases recommends patients with CHB receive monitoring of disease activity, including ALT, hepatitis B virus (HBV) DNA, hepatitis B e-antigen (HBeAg), and liver imaging for patients who experience an increased risk for HCC. HBV antiviral therapy is recommended for patients wi…
Hepatitis B Virus Studies (3 works) · Hepatitis C virus research (3 works) · Medicine (3 works) · Environmental health (2 works) · Family medicine (2 works) · Hepatitis Viruses Studies and Epidemiology (2 works) · Virology (2 works) · China (1 work) · Chronic hepatitis (1 work) · Cross-sectional study (1 work)